Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Paraphrase, not own words

Rules 1.1.0 · as of 14 Sep 2026

Quote

Paraphrase, not own words

“he expects another company, Compass Pathways, to win the race for FDA approval with a psilocybin treatment.”
· Advocates say the push for psychedelic medicine isn't over, post-FDA rejection (WBUR) · interview

Compass Pathways' psilocybin will be FDA-approved before Lykos's MDMA therapy.

The only record of the claim is a third party's paraphrase or a secondhand report; the forecaster's own words are not available. Shown as a row, never coded or scored.